Science/Health news

The researchers from the Mayo Clinic and the University of Iowa have new insight into an important "fuel gauge" in muscle. They've also uncovered evidence in mice that treatments designed to disrupt those so-called sarcolemmal ATP-sensitive K+ (KATP) channels specifically in muscles might allow us to control our weight by increasing the number of calories our muscles will burn with regular activity or exercise.

Ben W. Strowbridge, PhD, associate professor of neuroscience and physiology/biophysics, and Phillip Larimer, PhD, a MD/PhD student in the neurosciences graduate program at Case Western Reserve University School of Medicine, are the first to create stimulus-specific sustained activity patterns in brain circuits maintained in vitro.

It’s sometimes said that dermatologists do one of two things (though it’s not dermatologists who say it): Faced with a skin disease that’s too dry, they try to wet it; if the disease is too wet, they try to dry it.

Up to 25% of cancer patients develop metastases in the brain – often long after successful treatment of the primary tumor. In almost all such cases, the prognosis is poor. The mechanisms responsible for the appearance of brain metastases have long been mysterious.

Fighting an illness is not just about fighting the bacteria or viruses that cause it, it also has to do with your genes. In new research from Rockefeller University and the Necker Medical School in Paris, scientists have identified a gene mutation that makes children susceptible to a severe form of mycobacterial disease, any disease caused by species of Mycobacterium such as tuberculosis and leprosy.

In a new study available online and in a future issue of the journal Nature, lung-cancer experts in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center worked with scientists from the Cancer Genome Project in the United Kingdom to determine the entire genetic sequence of cancer cells from a patient with small-cell lung cancer (SCLC).

The program is led by the National Heart, Lung, and Blood Institute (NHLBI), in partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Behavioral and Social Sciences Research (OBSSR).

SOLID-TIMI 52 is a randomised, placebo-controlled, double-blind trial in men and women with ACS. The study will evaluate the clinical efficacy of long-term use of darapladib as compared with placebo when both are added to standard of care (which may include a statin, aspirin and blood pressure medications).

Siemens Healthcare and SAP AG (NYSE: SAP) signed an agreement today whereby SAP will resell in selected target markets the Siemens Healthcare hospital information system (HIS) i.s.h.med - a leading health information system for the clinical setting that helps healthcare providers improve efficiencies, contributing to improved patient care and the management information system i.c.m.health.

New N-STORM Super Resolution microscope system exceeds traditional diffraction limits by an order of magnitude and is capable of 3D image acquisition

UT Southwestern Medical Center researchers have found that a naturally occurring protein — transforming growth factor beta1 (TGF-ß1) — which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.

Responding directly to customer concerns, Philips’ latest healthcare solutions address financial needs by leveraging innovation

Medical professionals, expecting parents can see fetus in unprecedented detail with 3D ultrasound technology and NVIDIA 3D Vision Glasses

Researchers using functional magnetic resonance imaging (fMRI) to study brain activation have found that men and women respond differently to positive and negative stimuli, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

On the eve of World AIDS Day, WHO is releasing new recommendations on treatment, prevention and infant feeding in the context of HIV, based on the latest scientific evidence.

Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle - Virus' Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessation

The Intel Health Guide continues to help address chronic care challenges with the addition of a new reseller and several new customers.

Quest Diagnostics Health Trends(TM) Report based on results of more than 142,000 patient specimens tested for 2009 H1N1 influenza virus since May 2009

IBM (NYSE: IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world’s leading causes of death, cardiovascular disease*.

New Analytics Platform Will Help Rizzoli Institute Access Vital Family History Records and Medical Imaging to Advance Treatment of Hereditary Diseases